Twist Financial Statements From 2010 to 2022

TWST
 Stock
  

USD 52.64  4.11  8.47%   

Twist Bioscience financial statements provide useful quarterly and yearly information to potential Twist Bioscience Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Twist Bioscience financial statements helps investors assess Twist Bioscience's valuation, profitability, and current liquidity needs.
There are currently fourty-four fundamental trend indicators for Twist Bioscience Corp that can be evaluated and compared over time across competition. Make sure you double-check Twist Bioscience's current fundamentals against the performance from 2010 to 2022 and make sure the trends continue to evolve in the right direction.
Net Income Per Employee is likely to drop to about (226.5 K) in 2022. Revenue Per Employee is likely to drop to about 150.2 K in 2022.
  
Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist main balance sheet or income statement drivers, such as Direct Expenses of 78.3 M, Revenues of 128.5 M or Weighted Average Shares of 46.9 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0049, PPandE Turnover of 2.94 or Receivables Turnover of 6.31. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules. It can also supplement Twist Bioscience's financial leverage analysis and stock options assessment as well as various Twist Bioscience Technical models . Additionally, take a look at the analysis of Twist Bioscience Correlation against competitors.

Twist Bioscience Revenues

128.5 Million

Twist Bioscience Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets681.8 M631.9 M250.9 M
Increasing
Slightly volatile
Cash and Equivalents452.3 M419.2 M135.5 M
Increasing
Slightly volatile
Total Liabilities117.8 M109.1 M46.6 M
Increasing
Slightly volatile
Shareholders Equity564 M522.7 M204.3 M
Increasing
Slightly volatile
Current Assets530.7 M491.8 M198.6 M
Increasing
Slightly volatile
Current Liabilities61.2 M56.7 M25.2 M
Increasing
Slightly volatile
Accounts Payable14.5 M13.4 M6.3 M
Increasing
Slightly volatile
Receivables27.7 M25.7 M10.2 M
Increasing
Slightly volatile
Inventories30.9 M28.6 M9.7 M
Increasing
Slightly volatile

Twist Bioscience Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues128.5 M119.1 M44.2 M
Increasing
Slightly volatile
Weighted Average Shares46.9 M43.4 M17 M
Increasing
Slightly volatile
Weighted Average Shares Diluted46.9 M43.4 M17 M
Increasing
Slightly volatile
Direct Expenses78.3 M72.6 M34.8 M
Increasing
Slightly volatile

Twist Bioscience Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow from Financing319.7 M296.3 M152.1 M
Increasing
Slightly volatile
Net Cash Flow from Investing151.6 M140.5 M3.5 M
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Gross Margin37.9535.17(4.3009)
Increasing
Slightly volatile
Asset Turnover0.230.220.195
Increasing
Slightly volatile
Sales per Share3.763.152.6719
Increasing
Slightly volatile
Debt to Equity Ratio0.00320.00310.1146
Decreasing
Slightly volatile
Current Ratio7.087.87.0199
Increasing
Slightly volatile
Total Assets Per Share19.7916.3121.0539
Decreasing
Slightly volatile
Receivables Turnover6.315.546.4005
Decreasing
Slightly volatile
Inventory Turnover4.324.2111.0631
Decreasing
Slightly volatile
PPandE Turnover2.943.421.8705
Increasing
Slightly volatile
Cash and Equivalents Turnover0.510.430.5016
Increasing
Slightly volatile
Accounts Payable Turnover9.8112.076.7591
Increasing
Slightly volatile
Accrued Expenses Turnover4.264.763.2777
Increasing
Slightly volatile
Long Term Debt to Equity0.00490.00480.0994
Decreasing
Slightly volatile
Quick Ratio6.577.236.5977
Increasing
Stable
Net Current Assets as percentage of Total Assets61.6661.9766.6748
Increasing
Very volatile
Revenue to Assets0.160.170.1201
Increasing
Slightly volatile

Twist Bioscience Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Revenue Per Employee150.2 K182.7 K97.5 K
Increasing
Slightly volatile

Twist Fundamental Market Drivers

Forward Price Earnings-10.13
Short Percent Of Float11.95%
Average Daily Volume Last 10 Day845.01k
Shares Short Prior Month6.26M
Average Daily Volume In Three Month1.25M
Date Short Interest15th of July 2022
Fifty Day Average37.19
Two Hundred Day Average60.52

Twist Upcoming Events

Upcoming Quarterly Report3rd of February 2022
Next Financial Report5th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End28th of November 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

About Twist Bioscience Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Twist Bioscience income statement, its balance sheet, and the statement of cash flows. Twist Bioscience investors use historical funamental indicators, such as Twist Bioscience's revenue or net income, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may use each financial statement separately, they are all related. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Twist Bioscience's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Twist Bioscience Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Twist Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Revenues119.1 M128.5 M
Revenue to Assets 0.17  0.16 
Revenue Per Employee182.7 K150.2 K
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California. Twist Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 652 people.

Twist Bioscience Investors Sentiment

The influence of Twist Bioscience's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Twist. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Twist Bioscience's public news can be used to forecast risks associated with investment in Twist. The trend in average sentiment can be used to explain how an investor holding Twist can time the market purely based on public headlines and social activities around Twist Bioscience Corp. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Twist Bioscience's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Twist Bioscience's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Twist Bioscience's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Twist Bioscience.

Twist Bioscience Implied Volatility

    
  103.22  
Twist Bioscience's implied volatility exposes the market's sentiment of Twist Bioscience Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Twist Bioscience's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Twist Bioscience stock will not fluctuate a lot when Twist Bioscience's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Twist Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Twist Bioscience's short interest history, or implied volatility extrapolated from Twist Bioscience options trading.

Currently Active Assets on Macroaxis

Additionally, take a look at the analysis of Twist Bioscience Correlation against competitors. Note that the Twist Bioscience Corp information on this page should be used as a complementary analysis to other Twist Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Twist Stock analysis

When running Twist Bioscience Corp price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
B
Quarterly Revenue Growth YOY
0.6
Return On Assets
-0.17
Return On Equity
-0.29
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine Twist Bioscience value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.